Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3UW5

Crystal structure of the BIR domain of MLIAP bound to GDC0152

3UW5 の概要
エントリーDOI10.2210/pdb3uw5/pdb
関連するBIRD辞書のPRD_IDPRD_001020
分子名称Baculoviral IAP repeat-containing protein 7, Baculoviral IAP repeat-containing protein 4, GDC-0152, ZINC ION, ... (5 entities in total)
機能のキーワードapoptosis inhibitor, bir domain
由来する生物種Homo sapiens (human)
詳細
細胞内の位置Cytoplasm: P98170
タンパク質・核酸の鎖数4
化学式量合計27465.27
構造登録者
Maurer, B.,Hymowitz, S.G. (登録日: 2011-11-30, 公開日: 2012-02-22, 最終更新日: 2025-03-26)
主引用文献Flygare, J.A.,Beresini, M.,Budha, N.,Chan, H.,Chan, I.T.,Cheeti, S.,Cohen, F.,Deshayes, K.,Doerner, K.,Eckhardt, S.G.,Elliott, L.O.,Feng, B.,Franklin, M.C.,Reisner, S.F.,Gazzard, L.,Halladay, J.,Hymowitz, S.G.,La, H.,Lorusso, P.,Maurer, B.,Murray, L.,Plise, E.,Quan, C.,Stephan, J.P.,Young, S.G.,Tom, J.,Tsui, V.,Um, J.,Varfolomeev, E.,Vucic, D.,Wagner, A.J.,Wallweber, H.J.,Wang, L.,Ware, J.,Wen, Z.,Wong, H.,Wong, J.M.,Wong, M.,Wong, S.,Yu, R.,Zobel, K.,Fairbrother, W.J.
Discovery of a Potent Small-Molecule Antagonist of Inhibitor of Apoptosis (IAP) Proteins and Clinical Candidate for the Treatment of Cancer (GDC-0152).
J.Med.Chem., 55:4101-4113, 2012
Cited by
PubMed Abstract: A series of compounds were designed and synthesized as antagonists of cIAP1/2, ML-IAP, and XIAP based on the N-terminus, AVPI, of mature Smac. Compound 1 (GDC-0152) has the best profile of these compounds; it binds to the XIAP BIR3 domain, the BIR domain of ML-IAP, and the BIR3 domains of cIAP1 and cIAP2 with K(i) values of 28, 14, 17, and 43 nM, respectively. These compounds promote degradation of cIAP1, induce activation of caspase-3/7, and lead to decreased viability of breast cancer cells without affecting normal mammary epithelial cells. Compound 1 inhibits tumor growth when dosed orally in the MDA-MB-231 breast cancer xenograft model. Compound 1 was advanced to human clinical trials, and it exhibited linear pharmacokinetics over the dose range (0.049 to 1.48 mg/kg) tested. Mean plasma clearance in humans was 9 ± 3 mL/min/kg, and the volume of distribution was 0.6 ± 0.2 L/kg.
PubMed: 22413863
DOI: 10.1021/jm300060k
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.71 Å)
構造検証レポート
Validation report summary of 3uw5
検証レポート(詳細版)ダウンロードをダウンロード

252456

件を2026-04-22に公開中

PDB statisticsPDBj update infoContact PDBjnumon